एपीए उद्धरण

List, A. F., Bennett, J. M., Sekeres, M. A., Skikne, B., Fu, T., Shammo, J. M., . . . Giagounidis, A. (2014). Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS. Nature Publishing Group.

शिकागो स्टाइल उद्धरण

List, A F., J M. Bennett, M A. Sekeres, B. Skikne, T. Fu, J M. Shammo, S D. Nimer, R D. Knight, और A. Giagounidis. Extended Survival and Reduced Risk of AML Progression in Erythroid-responsive Lenalidomide-treated Patients With Lower-risk Del(5q) MDS. Nature Publishing Group, 2014.

एमएलए उद्धरण

List, A F., et al. Extended Survival and Reduced Risk of AML Progression in Erythroid-responsive Lenalidomide-treated Patients With Lower-risk Del(5q) MDS. Nature Publishing Group, 2014.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.